Table 2. Levels of C-reactive protein and sP-selectin at study start, after 18 months and at study end in the placebo group, and in the active treatment group.
CRP baseline (mg/mL) | CRP 18 months (mg/mL) | CRP 48 months (mg/mL9 | sP-selectin baseline (ng/ml) | sP-selectin 18 months (ng/mL) | sP-selectin 48 months (ng/mL) | |
---|---|---|---|---|---|---|
Placebo group, mean (SD) | 4.84 (12.0) | 3.69 (3.7) | 5.05 (6.2) | 56.6 (26.3 | 57.9 (24.8) | 72.3 (35.9) |
Active treatment, mean (SD) | 4.06 (11.7) | 2.61 (3.2) | 2.07 (2.3) | 55.9 (22.4) | 54.5 (21.1) | 58.0 (19.2) |
Note: CRP: C-reactive protein.